Vaxil Bio Ltd. (VXL.V) TSXV

0.19

+0(+0.00%)

Updated at October 09 10:21AM

Currency In CAD

Valuation

Market Cap28.08M
Enterprise Value27.63M
P/E Ratio-5.26
PEG Ratio-0.01
Price/Sales Ratio0
Price/Book Ratio0.75
Enterprise/Revenue0
Enterprise/EBITDA-0.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.14
Return On Equity-0.14

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-178,000
Net Income-178,000
Diluted EPS-0

Balance Sheet

Total Cash347,000
Total Cash/Share0.13
Total Debt0
Total Debt/Equity0
Current Ratio104.17
Book Value Per Share0.25

Price History

52-Week Change-7.32
52-Week High0.5
52-Week Low0.01
Moving Average 50 Days0.18
Moving Average 200 Days0.14

Statistics

Average Volume1,448
Shares Outstanding2.74M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 15, 2025